NCT06059937View on ClinicalTrials.gov

Evaluation of Cardiovascular Risk After Preeclampsia in General Practitioners and Patients

CompletedOBSERVATIONAL
Enrollment

155

Participants

Timeline

Start Date

February 26, 2024

Primary Completion Date

February 11, 2025

Study Completion Date

February 11, 2025

Conditions
Patients Hospitalized for Pre-eclampsia
Interventions
OTHER

Patient with pre-eclampsia

Cardiovascular risk assessment by the general practitioner in the year following pre-eclampsia

Trial Locations (1)

54500

CHRU de NANCY, Vandœuvre-lès-Nancy

All Listed Sponsors
lead

Central Hospital, Nancy, France

OTHER

NCT06059937 - Evaluation of Cardiovascular Risk After Preeclampsia in General Practitioners and Patients | Biotech Hunter | Biotech Hunter